WATSON 453
Pill imprint WATSON 453 has been identified as Guanfacine hydrochloride 2 mg.
Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy.
Guanfacine 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Guanfacine hydrochloride Images
- Imprint:
-
WATSON 453
- Strength:
- 2 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
D&C Yellow No. 10
FD&C Red No. 40
povidone
stearic acid
microcrystalline cellulose
aluminum oxide
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0453
Advertisement
More Guanfacine Hydrochloride resources
- Guanfacine (Wolters Kluwer)
- Guanfacine Extended-Release Tablets (Wolters Kluwer)
- guanfacine (Cerner Multum)
- guanfacine (Micromedex) - Includes Dosage Information
- Guanfacine (AHFS DI)
- Guanfacine (FDA)
- Guanfacine (Wolters Kluwer)
- Guanfacine Hydrochloride (Wolters Kluwer)
Search Again
